Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mohammad Abusamak, Mohammad Al-Tamimi, Haider Al-Waeli, Kawkab Tahboub, Wenji Cai, Martin Morris, Faleh Tamimi & Belinda Nicolau. (2023) Chronotherapy in dentistry: A scoping review. Chronobiology International 40:5, pages 684-697.
Read now
Read now
P.X Zhang, F Jin, Z.L Li, W.L Wu, Y.Y Li, J.H Long, G.Y Chen, X.X Chen, J.Y Gan, X.Y Gong, Q. Y. He & T Bi. (2018) A randomized phase II trial of induction chemotherapy followed by cisplatin chronotherapy versus constant rate delivery combined with radiotherapy. Chronobiology International 35:2, pages 240-248.
Read now
Read now
Kai Yang, Ningbo Zhao, Dan Zhao, Dan Chen & Yadong Li. (2013) The drug efficacy and adverse reactions in a mouse model of oral squamous cell carcinoma treated with oxaliplatin at different time points during a day. Drug Design, Development and Therapy 7, pages 511-517.
Read now
Read now
Francesco Portaluppi. (2007) Consistency and Accuracy of the Medical Subject Headings® Thesaurus for Electronic Indexing and Retrieval of Chronobiologic References. Chronobiology International 24:6, pages 1213-1229.
Read now
Read now
Articles from other publishers (16)
Markella I Printezi, Aoife B Kilgallen, Marinde J G Bond, Urška Štibler, Marrit Putker, Arco J Teske, Maarten J Cramer, Cornelis J A Punt, Joost P G Sluijter, Alwin D R Huitema, Anne M May & Linda W van Laake. (2022) Toxicity and efficacy of chronomodulated chemotherapy: a systematic review. The Lancet Oncology 23:3, pages e129-e143.
Crossref
Crossref
Yool Lee, Jeffrey M. Field & Amita Sehgal. (2021) Circadian Rhythms, Disease and Chronotherapy. Journal of Biological Rhythms 36:6, pages 503-531.
Crossref
Crossref
Yool Lee. (2021) Roles of circadian clocks in cancer pathogenesis and treatment. Experimental & Molecular Medicine 53:10, pages 1529-1538.
Crossref
Crossref
Theodore J. Wigle, Elena V. Tsvetkova, Stephen A. Welch & Richard B. Kim. (2019) DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report. Pharmaceutics 11:5, pages 199.
Crossref
Crossref
Narin Ozturk, Dilek Ozturk, Ibrahim Halil Kavakli & Alper Okyar. (2017) Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy. International Journal of Molecular Sciences 18:10, pages 2168.
Crossref
Crossref
Bart A. W. Jacobs, Maarten J. Deenen, Dick Pluim, J. G. Coen Hasselt, Martin D. Krähenbühl, Robin M. J. M. Geel, Niels Vries, Hilde Rosing, Didier Meulendijks, Artur M. Burylo, Annemieke Cats, Jos H. Beijnen, Alwin D. R. Huitema & Jan H. M. Schellens. (2016) Pronounced between‐subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers. British Journal of Clinical Pharmacology 82:3, pages 706-716.
Crossref
Crossref
Khalid O Alfarouk, Christian-Martin Stock, Sophie Taylor, Megan Walsh, Abdel Khalig Muddathir, Daniel Verduzco, Adil H H Bashir, Osama Y Mohammed, Gamal O Elhassan, Salvador Harguindey, Stephan J Reshkin, Muntaser E Ibrahim & Cyril Rauch. (2015) Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell International 15:1.
Crossref
Crossref
Francis Lévi, Alper Okyar, Sandrine Dulong, Pasquale F. Innominato & Jean Clairambault. (2010) Circadian Timing in Cancer Treatments. Annual Review of Pharmacology and Toxicology 50:1, pages 377-421.
Crossref
Crossref
C. Qvortrup, B.V. Jensen, T. Fokstuen, S.E. Nielsen, N. Keldsen, B. Glimelius, B. Bjerregaard, J. Mejer, F.O. Larsen & P. Pfeiffer. (2010) A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer. Annals of Oncology 21:1, pages 87-91.
Crossref
Crossref
Mohamed Bouchahda, René Adam, Sylvie Giacchetti, Denis Castaing, Catherine Brezault-Bonnet, Dominique Hauteville, Pasquale F. Innominato, Christian Focan, David Machover & Francis Lévi. (2009) Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer. Cancer 115:21, pages 4990-4999.
Crossref
Crossref
Andreas-Claudius Hoffmann, Jan Brabender, Ralf Metzger, Fredericke Ling, Ute Warnecke-Eberz, Georg Lurje, Arnulf H. Hoelscher, Paul M. Schneider & Daniel Vallböhmer. (2009) Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection. Journal of Surgical Oncology 99:5, pages 296-301.
Crossref
Crossref
Atilla Altinok, Francis Lévi & Albert Goldbeter. (2009) Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling. European Journal of Pharmaceutical Sciences 36:1, pages 20-38.
Crossref
Crossref
Francis Lévi, Atilla Altinok, Jean Clairambault & Albert Goldbeter. (2008) Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 366:1880, pages 3575-3598.
Crossref
Crossref
Francis Lévi, Christian Focan, Abdoulaye Karaboué, Virginie de la Valette, Danielle Focan-Henrard, Benoît Baron, Françoise Kreutz & Sylvie Giacchetti. (2007) Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Advanced Drug Delivery Reviews 59:9-10, pages 1015-1035.
Crossref
Crossref
Francis LeviUeli Schibler. (2007) Circadian Rhythms: Mechanisms and Therapeutic Implications. Annual Review of Pharmacology and Toxicology 47:1, pages 593-628.
Crossref
Crossref
Dany Gholam, Sylvie Giacchetti, Catherine Brézault-Bonnet, Mohamed Bouchahda, Dominique Hauteville, René Adam, Béatrice Ducot, Odile Ghémard, Francis Kustlinger, Claude Jasmin & Francis Lévi. (2006) Chronomodulated Irinotecan, Oxaliplatin, and Leucovorin-Modulated 5-Fluorouracil as Ambulatory Salvage Therapy in Patients with Irinotecan- and Oxaliplatin-Resistant Metastatic Colorectal Cancer. The Oncologist 11:10, pages 1072-1080.
Crossref
Crossref